Cargando…
Experience of using beta-D-glucan assays in the intensive care unit
Autores principales: | Dagens, A., Mughal, N., Sisson, A., Moore, L. S. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948823/ https://www.ncbi.nlm.nih.gov/pubmed/29751822 http://dx.doi.org/10.1186/s13054-018-2044-7 |
Ejemplares similares
-
Performance evaluation of the (1,3)-β-D-glucan detection assay in non-intensive care unit adult patients
por: Murri, Rita, et al.
Publicado: (2018) -
Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit
por: Mikulska, Malgorzata, et al.
Publicado: (2022) -
360. The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
por: Son, Hyo-Ju
Publicado: (2022) -
Beta-D-Glucan in Patients with Haematological Malignancies
por: Mikulska, Malgorzata, et al.
Publicado: (2021) -
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index
por: Posteraro, Brunella, et al.
Publicado: (2011)